The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ABSOLUTE: A phase 3 trial of nanoparticle albumin-bound paclitaxel (nab-PTX) versus solvent-based paclitaxel (sb-PTX) in patients with pre-treated advanced gastric cancer (AGC)—Efficacy and QOL results.
 
Keisuke Koeda
No Relationships to Disclose
 
Kohei Shitara
Honoraria - Bayer; Bristol-Myers Squibb; Chugai Pharma; Novartis; Takeda
Consulting or Advisory Role - Bayer (Inst); Chugai Pharma (Inst); Lilly (Inst); Takeda (Inst)
Research Funding - Bayer (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Lilly (Inst); MSD (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Yakult Pharmaceutical (Inst)
 
Atsuo Takashima
Honoraria - Chugai Pharma; Merck Serono; Takeda
Consulting or Advisory Role - Taiho Pharmaceutical (Inst)
 
Kazumasa Fujitani
Honoraria - Taiho Pharmaceutical
 
Hironori Tsujimoto
No Relationships to Disclose
 
Akihito Tsuji
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Merck Serono; Taiho Pharmaceutical; Takeda
Speakers' Bureau - Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda
 
Eiji Oki
Speakers' Bureau - Taiho Pharmaceutical
 
Akinori Takagane
No Relationships to Disclose
 
Masakazu Takagi
No Relationships to Disclose
 
Yasuo Hamamoto
No Relationships to Disclose
 
Hideo Baba
Honoraria - Bristol-Myers Squibb Japan; Taiho Pharmaceutical
Consulting or Advisory Role - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical (Inst)
 
Yasushi Omuro
Research Funding - Taiho Pharmaceutical (Inst)
 
Hiroyuki Okuda
No Relationships to Disclose
 
Yasuyuki Nakano
No Relationships to Disclose
 
Naotoshi Sugimoto
No Relationships to Disclose
 
Michio Nakamura
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo
Research Funding - Astellas Pharma (Inst); Takeda (Inst); Zeria Pharmaceutical (Inst)
 
Kazuhiro Imamura
Honoraria - Covidien; Johnson & Johnson
 
Daisuke Ichikawa
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst); Yakult Pharmaceutical (Inst)
 
Hiroyuki Kuwano
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Yakult Pharmaceutical
Research Funding - Chugai Pharma; Taiho Pharmaceutical; Yakult Pharmaceutical
Travel, Accommodations, Expenses - Chugai Pharma; Taiho Pharmaceutical; Yakult Pharmaceutical
 
Wasaburo Koizumi
Honoraria - Taiho Pharmaceutical
Consulting or Advisory Role - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical (Inst)